13G Filing: Cephalon Inc and Ignyta Inc. (NASDAQ:RXDX)

---

CUSIP No. 451731103		13G/A		Page 4 of 7

Item 1(a).

Name of Issuer:

Ignyta, Inc. (the Issuer)

Item 1(b).

Address of Issuers Principal Executive Offices:

4545 Towne Centre Ct.

San Diego, California 92121

Item 2(a).

Name of Persons Filing:

This Statement is filed by Cephalon, Inc., a Delaware
corporation (Cephalon) and Teva Pharmaceutical Industries Limited, an Israel company and parent of Cephalon (Teva). Teva and Cephalon are collectively referred to as the Reporting Persons.

Teva, the parent of Cephalon, may be deemed to have sole power to vote and sole power to dispose of shares of the Issuer directly owned by
Cephalon.

Item 2(b).

Address of Principal Business Office or, if None, Residence:

Cephalon, Inc.

1090 Horsham Road

North Wales,
PA 19454

Teva Pharmaceutical Industries Limited

5 Basel Street

PO Box 3190

Petach Tikva 4951033

Israel

Item 2(c).

Citizenship:

Cephalon, Inc. is a Delaware corporation and United States citizen.

Teva Pharmaceutical Industries Limited is an Israeli corporation and an Israeli citizen.

Item 2(d).

Title of Class of Securities:

Common Stock, par value $0.0001 per share
(Common Stock).

Item 2(e).

CUSIP Number:

451731103

Item 3.

If this statement is filed pursuant to
§§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a)		☐		Broker or dealer registered under Section 15 of the Act;
(b)		☐		Bank as defined in Section 3(a)(6) of the Act;
(c)		☐		Insurance company as defined in Section 3(a)(19) of the Act;
(d)		☐		Investment company registered under Section 8 of the Investment Company Act of 1940;
(e)		☐		An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);